News

generatio is performing research to better understand the relationship between symptoms and environmental factors involved with the multifactorial genetic disorder PSSM2 (equine myopathy). Owners of all horses that have been tested for PSSM2 by generatio, EquiSeq, or through the IAFH are invited to compete the scientific survey for each tested horse.

Meet us at the HKM Bundeschampionat in Warendorf! From Wednesday, August 31 to Sunday, September 4, you can meet our team at the Bundeschampionat in Warendorf and learn more about our animal genetics and horse diagnostics!

Generatio has established a generous subsidy as part of an IAFH research project on PSSM2. The requirement for the discounted test is consent to use the PSSM2 findings in scientific research. Requests for the IAFH testing must be submitted directly to the respective IAFH breeding association, through which billing will also be done.

At the same time, we are pleased to announce that we will reduce the price of the PSSM2 6-variant panel test at generatio to 200 € (excl. VAT) as of April 1, 2022.

There is currently much discussion among horse breeders and owners about the group of hereditary muscle diseases known as PSSM2.  The need for more data on the frequency and severity of these mutations in different breed populations is clear.  Generatio GmbH – Center for Animal Genetics, the exclusive European patent holder of the EquiSeq PSSM2 variants[MC1] , has therefore established a unique cooperation with the International Association of Future Horse Breeding (IAFH) to test horses of Holstein, Trakehner, Oldenburg, Oldenburg Springpferd, and Westphalian populations.

PSSM1 and PSSM2 are hereditary muscle disorders that have been identified in many breeds, including the Connemara pony.  In order to better learn about the impact of these disorders in the breed, the Connemara Pony PSSM Research Group and Generatio-CAG have established a DNA Program for testing.